Compare FN & HOLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FN | HOLX |
|---|---|---|
| Founded | 1999 | 1985 |
| Country | Cayman Islands | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Medical Electronics |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.1B | 16.6B |
| IPO Year | 2007 | 1995 |
| Metric | FN | HOLX |
|---|---|---|
| Price | $513.62 | $75.17 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 8 | 13 |
| Target Price | ★ $489.14 | $77.89 |
| AVG Volume (30 Days) | 566.8K | ★ 2.3M |
| Earning Date | 05-04-2026 | 04-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 13.21 | N/A |
| EPS | ★ 5.77 | 0.79 |
| Revenue | $3,419,327,000.00 | ★ $4,100,500,000.00 |
| Revenue This Year | $36.90 | $4.74 |
| Revenue Next Year | $18.35 | $5.03 |
| P/E Ratio | ★ $87.44 | $95.08 |
| Revenue Growth | ★ 18.60 | 1.74 |
| 52 Week Low | $148.55 | $51.90 |
| 52 Week High | $632.99 | $75.75 |
| Indicator | FN | HOLX |
|---|---|---|
| Relative Strength Index (RSI) | 48.37 | 45.74 |
| Support Level | $429.50 | $74.53 |
| Resistance Level | $632.99 | $75.35 |
| Average True Range (ATR) | 36.45 | 0.22 |
| MACD | -7.55 | -0.06 |
| Stochastic Oscillator | 18.65 | 22.00 |
Fabrinet provides advance-level optical packaging and precision optical, electro-mechanical, and electronic manufacturing services to original equipment manufacturers of complex products, such as optical communication components, modules and sub-systems, industrial lasers, automotive components, medical devices, and sensors. The company offers a broad range of advance optical and electro-mechanical capabilities across the entire manufacturing process, including process design and engineering, supply chain management, manufacturing, complex printed circuit board assembly, advance-level of packaging, integration, final assembly, and testing. The company generates the majority of its revenue from North America and Asia-Pacific, with the rest from Europe.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.